These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 371860)

  • 1. Changes in pituitary gonadotropins during the amenorrhoea-galactorrhoea syndrome due to sulpiride.
    Buvat J; Thomas K; Racadot A; Blacker C; Buvat-Herbaut M; Ferin F; Linquette M
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):499-504. PubMed ID: 371860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
    Onda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and endocrinological analyses of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide.
    Aono T; Shioji T; Kinugasa T; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1978 Sep; 47(3):675-80. PubMed ID: 122411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin response to luteinizing hormone releasing hormone administration in secondary amenorrhea and galactorrhea syndromes.
    Wentz AC; Jones GS; Rocco L; Matthews RR
    Obstet Gynecol; 1975 Mar; 45(3):256-62. PubMed ID: 1089929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ Study of prolactin and blood gonadotropins in amenorrheas-galactorrhea. Dynamic exploation in 13 cases].
    Schaison G; Nathan C; L'Hermite M; Gilbert-Dreyfus
    Nouv Presse Med; 1975 Mar; 4(9):644-8. PubMed ID: 805417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amenorrhoea, galactorrhoea, and hyperprolactinaemia induced by methyldopa.
    Arze RS; Ramos JM; Rashid HU; Kerr DN
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):194. PubMed ID: 6789964
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.
    Tyson JE; Andreasson B; Huth J; Smith B; Zacur H
    Obstet Gynecol; 1975 Jul; 46(1):1-11. PubMed ID: 1153129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum prolactin and gonadotrophin levels before and after luteinizing hormone-releasing hormone in the investigation of amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Br J Obstet Gynaecol; 1978 Dec; 85(12):945-56. PubMed ID: 367427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised serum prolactin levels in amenorrhoea.
    Seppălă M; Hibroven E; Ranta T; Virkkunen P; Leppăluoto J
    Br Med J; 1975 May; 2(5966):305-6. PubMed ID: 1093605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired LH release following exogenous estrogen administration in patients with amenorrhea-galactorrhea syndrome.
    Aono T; Miyake A; Shioji T; Kinugasa T; Onishi T
    J Clin Endocrinol Metab; 1976 Apr; 42(4):696-702. PubMed ID: 177447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia.
    Simpson CW; Plunkett ER
    Fertil Steril; 1979 Nov; 32(5):510-7. PubMed ID: 115722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V; Kletzky O; March CM; Roy S; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.